Meanwhile, reduced risk of severe COVID-19 symptom is found associated with patients that has been prescribed with ACE inhibitor drugs (Hippisley-Cox et al., 2020), indicating the possible protective effect of ACE2 activity inhibition during the clinical treatment of COVID-19. The gene discussed is ACE; the disease is COVID-19.